Skip to main content
Top
Published in: Critical Care 4/2011

Open Access 01-08-2011 | Research

When should a diagnosis of influenza be considered in adults requiring intensive care unit admission? Results of population-based active surveillance in Toronto

Authors: Stefan P Kuster, Kevin C Katz, Joanne Blair, James Downey, Steven J Drews, Sandy Finkelstein, Rob Fowler, Karen Green, Jonathan Gubbay, Kazi Hassan, Stephen E Lapinsky, Tony Mazzulli, Donna McRitchie, Janos Pataki, Agron Plevneshi, Jeff Powis, David Rose, Alicia Sarabia, Carmine Simone, Andrew Simor, Allison McGeer

Published in: Critical Care | Issue 4/2011

Login to get access

Abstract

Introduction

There is a paucity of data about the clinical characteristics that help identify patients at high risk of influenza infection upon ICU admission. We aimed to identify predictors of influenza infection in patients admitted to ICUs during the 2007/2008 and 2008/2009 influenza seasons and the second wave of the 2009 H1N1 influenza pandemic as well as to identify populations with increased likelihood of seasonal and pandemic 2009 influenza (pH1N1) infection.

Methods

Six Toronto acute care hospitals participated in active surveillance for laboratory-confirmed influenza requiring ICU admission during periods of influenza activity from 2007 to 2009. Nasopharyngeal swabs were obtained from patients who presented to our hospitals with acute respiratory or cardiac illness or febrile illness without a clear nonrespiratory aetiology. Predictors of influenza were assessed by multivariable logistic regression analysis and the likelihood of influenza in different populations was calculated.

Results

In 5,482 patients, 126 (2.3%) were found to have influenza. Admission temperature ≥38°C (odds ratio (OR) 4.7 for pH1N1, 2.3 for seasonal influenza) and admission diagnosis of pneumonia or respiratory infection (OR 7.3 for pH1N1, 4.2 for seasonal influenza) were independent predictors for influenza. During the peak weeks of influenza seasons, 17% of afebrile patients and 27% of febrile patients with pneumonia or respiratory infection had influenza. During the second wave of the 2009 pandemic, 26% of afebrile patients and 70% of febrile patients with pneumonia or respiratory infection had influenza.

Conclusions

The findings of our study may assist clinicians in decision making regarding optimal management of adult patients admitted to ICUs during future influenza seasons. Influenza testing, empiric antiviral therapy and empiric infection control precautions should be considered in those patients who are admitted during influenza season with a diagnosis of pneumonia or respiratory infection and are either febrile or admitted during weeks of peak influenza activity.
Appendix
Available only for authorised users
Literature
1.
go back to reference ANZIC Influenza Investigators, Webb SA, Pettilä V, Seppelt I, Bellomo R, Bailey M, Cooper DJ, Cretikos M, Davies AR, Finfer S, Harrigan PW, Hart GK, Howe B, Iredell JR, McArthur C, Mitchell I, Morrison S, Nichol AD, Paterson DL, Peake S, Richards B, Stephens D, Turner A, Yung M: Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009, 361: 1925-1934.CrossRef ANZIC Influenza Investigators, Webb SA, Pettilä V, Seppelt I, Bellomo R, Bailey M, Cooper DJ, Cretikos M, Davies AR, Finfer S, Harrigan PW, Hart GK, Howe B, Iredell JR, McArthur C, Mitchell I, Morrison S, Nichol AD, Paterson DL, Peake S, Richards B, Stephens D, Turner A, Yung M: Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009, 361: 1925-1934.CrossRef
2.
go back to reference Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, Stelfox T, Bagshaw S, Choong K, Lamontagne F, Turgeon AF, Lapinsky S, Ahern SP, Smith O, Siddiqui F, Jouvet P, Khwaja K, McIntyre L, Menon K, Hutchison J, Hornstein D, Joffe A, Lauzier F, Singh J, Karachi T, Wiebe K, Olafson K, Ramsey C, Sharma S, Dodek P, Meade M, Hall R, Fowler RA, Canadian Critical Care Trials Group H1N1 Collaborative: Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009, 302: 1872-1879. 10.1001/jama.2009.1496PubMedCrossRef Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, Stelfox T, Bagshaw S, Choong K, Lamontagne F, Turgeon AF, Lapinsky S, Ahern SP, Smith O, Siddiqui F, Jouvet P, Khwaja K, McIntyre L, Menon K, Hutchison J, Hornstein D, Joffe A, Lauzier F, Singh J, Karachi T, Wiebe K, Olafson K, Ramsey C, Sharma S, Dodek P, Meade M, Hall R, Fowler RA, Canadian Critical Care Trials Group H1N1 Collaborative: Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009, 302: 1872-1879. 10.1001/jama.2009.1496PubMedCrossRef
3.
go back to reference Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, Poblano-Morales M, Baltazar-Torres JA, Bautista E, Martinez A, Martinez MA, Rivero E, Valdez R, Ruiz-Palacios G, Hernández M, Stewart TE, Fowler RA: Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009, 302: 1880-1887. 10.1001/jama.2009.1536PubMedCrossRef Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, Poblano-Morales M, Baltazar-Torres JA, Bautista E, Martinez A, Martinez MA, Rivero E, Valdez R, Ruiz-Palacios G, Hernández M, Stewart TE, Fowler RA: Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009, 302: 1880-1887. 10.1001/jama.2009.1536PubMedCrossRef
4.
go back to reference Farias JA, Fernández A, Monteverde E, Vidal N, Arias P, Montes MJ, Rodríguez G, Allasia M, Ratto ME, Jaén R, Meregalli C, Fiquepron K, Calvo AR, Siaba A, Albano L, Poterala R, Neira P, Esteban A: Critically ill infants and children with influenza A (H1N1) in pediatric intensive care units in Argentina. Intensive Care Med 2010, 36: 1015-1022. 10.1007/s00134-010-1853-1PubMedCrossRef Farias JA, Fernández A, Monteverde E, Vidal N, Arias P, Montes MJ, Rodríguez G, Allasia M, Ratto ME, Jaén R, Meregalli C, Fiquepron K, Calvo AR, Siaba A, Albano L, Poterala R, Neira P, Esteban A: Critically ill infants and children with influenza A (H1N1) in pediatric intensive care units in Argentina. Intensive Care Med 2010, 36: 1015-1022. 10.1007/s00134-010-1853-1PubMedCrossRef
5.
go back to reference Yang P, Deng Y, Pang X, Shi W, Li X, Tian L, Zhang Y, Wang X, Huang F, Raina MC, Wang Q: Severe, critical and fatal cases of 2009 H1N1 influenza in China. J Infect 2010, 61: 277-283. 10.1016/j.jinf.2010.07.010PubMedCrossRef Yang P, Deng Y, Pang X, Shi W, Li X, Tian L, Zhang Y, Wang X, Huang F, Raina MC, Wang Q: Severe, critical and fatal cases of 2009 H1N1 influenza in China. J Infect 2010, 61: 277-283. 10.1016/j.jinf.2010.07.010PubMedCrossRef
9.
go back to reference McGeer AJ: Diagnostic testing or empirical therapy for patients hospitalized with suspected influenza: what to do? Clin Infect Dis 2009,48(Suppl 1):S14-S19.PubMedCrossRef McGeer AJ: Diagnostic testing or empirical therapy for patients hospitalized with suspected influenza: what to do? Clin Infect Dis 2009,48(Suppl 1):S14-S19.PubMedCrossRef
10.
go back to reference Kuster SP, Drews S, Green K, Blair J, Davis I, Downey J, Fowler R, Katz K, Lapinsky S, McRitchie D, Pataki J, Powis J, Rose D, Sarabia A, Simone C, Simor A, Stewart T, McGeer A: Epidemiology of influenza-associated hospitalization in adults, Toronto, 2007/8. Eur J Clin Microbiol Infect Dis 2010, 29: 835-843. 10.1007/s10096-010-0935-xPubMedPubMedCentralCrossRef Kuster SP, Drews S, Green K, Blair J, Davis I, Downey J, Fowler R, Katz K, Lapinsky S, McRitchie D, Pataki J, Powis J, Rose D, Sarabia A, Simone C, Simor A, Stewart T, McGeer A: Epidemiology of influenza-associated hospitalization in adults, Toronto, 2007/8. Eur J Clin Microbiol Infect Dis 2010, 29: 835-843. 10.1007/s10096-010-0935-xPubMedPubMedCentralCrossRef
11.
go back to reference Daneman N, McGeer A, Green K, Low DE: Macrolide resistance in bacteremic pneumococcal disease: implications for patient management. Clin Infect Dis 2006, 43: 432-438. 10.1086/505871PubMedCrossRef Daneman N, McGeer A, Green K, Low DE: Macrolide resistance in bacteremic pneumococcal disease: implications for patient management. Clin Infect Dis 2006, 43: 432-438. 10.1086/505871PubMedCrossRef
12.
go back to reference McGeer A, Green KA, Plevneshi A, Shigayeva A, Siddiqi N, Raboud J, Low DE: Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007, 45: 1568-1575. 10.1086/523584PubMedCrossRef McGeer A, Green KA, Plevneshi A, Shigayeva A, Siddiqi N, Raboud J, Low DE: Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007, 45: 1568-1575. 10.1086/523584PubMedCrossRef
13.
go back to reference Vanderkooi OG, Low DE, Green K, Powis JE, McGeer A: Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis 2005, 40: 1288-1297. 10.1086/429242PubMedCrossRef Vanderkooi OG, Low DE, Green K, Powis JE, McGeer A: Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis 2005, 40: 1288-1297. 10.1086/429242PubMedCrossRef
14.
go back to reference Harrell FE Jr: Overview of maximum likelihood estimation. In Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York: Springer; 2001:179-214.CrossRef Harrell FE Jr: Overview of maximum likelihood estimation. In Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York: Springer; 2001:179-214.CrossRef
18.
go back to reference Falagas ME, Koletsi PK, Vouloumanou EK, Rafailidis PI, Kapaskelis AM, Rello J: Effectiveness and safety of neuraminidase inhibitors in reducing influenza complications: a meta-analysis of randomized controlled trials. J Antimicrob Chemother 2010, 65: 1330-1346. 10.1093/jac/dkq158PubMedCrossRef Falagas ME, Koletsi PK, Vouloumanou EK, Rafailidis PI, Kapaskelis AM, Rello J: Effectiveness and safety of neuraminidase inhibitors in reducing influenza complications: a meta-analysis of randomized controlled trials. J Antimicrob Chemother 2010, 65: 1330-1346. 10.1093/jac/dkq158PubMedCrossRef
19.
go back to reference Jefferson T, Demicheli V, Rivetti D, Jones M, Di Pietrantonj C, Rivetti A: Antivirals for influenza in healthy adults: systematic review. Lancet 2006, 367: 303-313. 10.1016/S0140-6736(06)67970-1PubMedCrossRef Jefferson T, Demicheli V, Rivetti D, Jones M, Di Pietrantonj C, Rivetti A: Antivirals for influenza in healthy adults: systematic review. Lancet 2006, 367: 303-313. 10.1016/S0140-6736(06)67970-1PubMedCrossRef
20.
go back to reference Moscona A: Neuraminidase inhibitors for influenza. N Engl J Med 2005, 353: 1363-1373. 10.1056/NEJMra050740PubMedCrossRef Moscona A: Neuraminidase inhibitors for influenza. N Engl J Med 2005, 353: 1363-1373. 10.1056/NEJMra050740PubMedCrossRef
21.
go back to reference Yu H, Liao Q, Yuan Y, Zhou L, Xiang N, Huai Y, Guo X, Zheng Y, van Doorn HR, Farrar J, Gao Z, Feng Z, Wang Y, Yang W: Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China. BMJ 2010, 341: c4779. 10.1136/bmj.c4779PubMedPubMedCentralCrossRef Yu H, Liao Q, Yuan Y, Zhou L, Xiang N, Huai Y, Guo X, Zheng Y, van Doorn HR, Farrar J, Gao Z, Feng Z, Wang Y, Yang W: Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China. BMJ 2010, 341: c4779. 10.1136/bmj.c4779PubMedPubMedCentralCrossRef
22.
go back to reference Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, McGeer AJ, Neuzil KM, Pavia AT, Tapper ML, Uyeki TM, Zimmerman RK, Expert Panel of the Infectious Diseases Society of America: Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009, 48: 1003-1032. 10.1086/598513PubMedCrossRef Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, McGeer AJ, Neuzil KM, Pavia AT, Tapper ML, Uyeki TM, Zimmerman RK, Expert Panel of the Infectious Diseases Society of America: Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009, 48: 1003-1032. 10.1086/598513PubMedCrossRef
23.
go back to reference Aoki FY, Macleod MD, Paggiaro P, Carewicz O, El Sawy A, Wat C, Griffiths M, Waalberg E, Ward P, IMPACT Study Group: Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob Chemother 2003, 51: 123-129. 10.1093/jac/dkg007PubMedCrossRef Aoki FY, Macleod MD, Paggiaro P, Carewicz O, El Sawy A, Wat C, Griffiths M, Waalberg E, Ward P, IMPACT Study Group: Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob Chemother 2003, 51: 123-129. 10.1093/jac/dkg007PubMedCrossRef
24.
go back to reference Baccam P, Beauchemin C, Macken CA, Hayden FG, Perelson AS: Kinetics of influenza A virus infection in humans. J Virol 2006, 80: 7590-7599. 10.1128/JVI.01623-05PubMedPubMedCentralCrossRef Baccam P, Beauchemin C, Macken CA, Hayden FG, Perelson AS: Kinetics of influenza A virus infection in humans. J Virol 2006, 80: 7590-7599. 10.1128/JVI.01623-05PubMedPubMedCentralCrossRef
25.
go back to reference Falagas ME, Vouloumanou EK, Baskouta E, Rafailidis PI, Polyzos K, Rello J: Treatment options for 2009 H1N1 influenza: evaluation of the published evidence. Int J Antimicrob Agents 2010, 35: 421-430. 10.1016/j.ijantimicag.2010.01.006PubMedCrossRef Falagas ME, Vouloumanou EK, Baskouta E, Rafailidis PI, Polyzos K, Rello J: Treatment options for 2009 H1N1 influenza: evaluation of the published evidence. Int J Antimicrob Agents 2010, 35: 421-430. 10.1016/j.ijantimicag.2010.01.006PubMedCrossRef
26.
go back to reference Gillissen A, Hoffken G: Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment. Med Microbiol Immunol 2002, 191: 165-168. 10.1007/s00430-002-0139-9PubMedCrossRef Gillissen A, Hoffken G: Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment. Med Microbiol Immunol 2002, 191: 165-168. 10.1007/s00430-002-0139-9PubMedCrossRef
27.
go back to reference Hayden FG, Osterhaus AD, Treanor JJ, Fleming DM, Aoki FY, Nicholson KG, Bohnen AM, Hirst HM, Keene O, Wightman K: Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. N Engl J Med 1997, 337: 874-880. 10.1056/NEJM199709253371302PubMedCrossRef Hayden FG, Osterhaus AD, Treanor JJ, Fleming DM, Aoki FY, Nicholson KG, Bohnen AM, Hirst HM, Keene O, Wightman K: Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. N Engl J Med 1997, 337: 874-880. 10.1056/NEJM199709253371302PubMedCrossRef
28.
go back to reference Ling LM, Chow AL, Lye DC, Tan AS, Krishnan P, Cui L, Win NN, Chan M, Lim PL, Lee CC, Leo YS: Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection. Clin Infect Dis 2010, 50: 963-969. 10.1086/651083PubMedCrossRef Ling LM, Chow AL, Lye DC, Tan AS, Krishnan P, Cui L, Win NN, Chan M, Lim PL, Lee CC, Leo YS: Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection. Clin Infect Dis 2010, 50: 963-969. 10.1086/651083PubMedCrossRef
29.
go back to reference Cunney RJ, Bialachowski A, Thornley D, Smaill FM, Pennie RA: An outbreak of influenza A in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2000, 21: 449-454. 10.1086/501786PubMedCrossRef Cunney RJ, Bialachowski A, Thornley D, Smaill FM, Pennie RA: An outbreak of influenza A in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2000, 21: 449-454. 10.1086/501786PubMedCrossRef
30.
go back to reference Oliveira EC, Lee B, Colice GL: Influenza in the intensive care unit. J Intensive Care Med 2003, 18: 80-91. 10.1177/0885066602250368PubMedCrossRef Oliveira EC, Lee B, Colice GL: Influenza in the intensive care unit. J Intensive Care Med 2003, 18: 80-91. 10.1177/0885066602250368PubMedCrossRef
31.
go back to reference Salgado CD, Farr BM, Hall KK, Hayden FG: Influenza in the acute hospital setting. Lancet Infect Dis 2002, 2: 145-155. 10.1016/S1473-3099(02)00221-9PubMedCrossRef Salgado CD, Farr BM, Hall KK, Hayden FG: Influenza in the acute hospital setting. Lancet Infect Dis 2002, 2: 145-155. 10.1016/S1473-3099(02)00221-9PubMedCrossRef
34.
go back to reference Uyeki TM: Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza. Pediatr Infect Dis J 2003, 22: 164-177.PubMed Uyeki TM: Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza. Pediatr Infect Dis J 2003, 22: 164-177.PubMed
35.
go back to reference Hurt AC, Alexander R, Hibbert J, Deed N, Barr IG: Performance of six influenza rapid tests in detecting human influenza in clinical specimens. J Clin Virol 2007, 39: 132-135. 10.1016/j.jcv.2007.03.002PubMedCrossRef Hurt AC, Alexander R, Hibbert J, Deed N, Barr IG: Performance of six influenza rapid tests in detecting human influenza in clinical specimens. J Clin Virol 2007, 39: 132-135. 10.1016/j.jcv.2007.03.002PubMedCrossRef
36.
go back to reference Rahman M, Kieke BA, Vandermause MF, Mitchell PD, Greenlee RT, Belongia EA: Performance of Directigen flu A+B enzyme immunoassay and direct fluorescent assay for detection of influenza infection during the 2004-2005 season. Diagn Microbiol Infect Dis 2007, 58: 413-418. 10.1016/j.diagmicrobio.2007.03.011PubMedCrossRef Rahman M, Kieke BA, Vandermause MF, Mitchell PD, Greenlee RT, Belongia EA: Performance of Directigen flu A+B enzyme immunoassay and direct fluorescent assay for detection of influenza infection during the 2004-2005 season. Diagn Microbiol Infect Dis 2007, 58: 413-418. 10.1016/j.diagmicrobio.2007.03.011PubMedCrossRef
37.
go back to reference Rothberg MB, Haessler SD, Brown RB: Complications of viral influenza. Am J Med 2008, 121: 258-264. 10.1016/j.amjmed.2007.10.040PubMedCrossRef Rothberg MB, Haessler SD, Brown RB: Complications of viral influenza. Am J Med 2008, 121: 258-264. 10.1016/j.amjmed.2007.10.040PubMedCrossRef
Metadata
Title
When should a diagnosis of influenza be considered in adults requiring intensive care unit admission? Results of population-based active surveillance in Toronto
Authors
Stefan P Kuster
Kevin C Katz
Joanne Blair
James Downey
Steven J Drews
Sandy Finkelstein
Rob Fowler
Karen Green
Jonathan Gubbay
Kazi Hassan
Stephen E Lapinsky
Tony Mazzulli
Donna McRitchie
Janos Pataki
Agron Plevneshi
Jeff Powis
David Rose
Alicia Sarabia
Carmine Simone
Andrew Simor
Allison McGeer
Publication date
01-08-2011
Publisher
BioMed Central
Published in
Critical Care / Issue 4/2011
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc10331

Other articles of this Issue 4/2011

Critical Care 4/2011 Go to the issue